Hotchkis & Wiley Capital Management
PFE icon

Hotchkis & Wiley Capital Management’s Pfizer PFE Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-135,755
Closed -$3.82M – 201
2014
Q2 		$3.82M Sell
135,755
-68,932
-34% -$1.96M 0.01% 172
2014
Q1 		$6.24M Sell
204,687
-738
-0.4% -$22K 0.02% 160
2013
Q4 		$5.97M Sell
205,425
-7,588
-4% -$221K 0.03% 156
2013
Q3 		$5.8M Sell
213,013
-3,057
-1% -$83.2K 0.03% 159
2013
Q2 		$5.74M Buy
+216,070
New +$5.97M 0.03% 143

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management's PFE Position: Q3 2014 in Review

Hotchkis & Wiley Capital Management sold out of Pfizer (PFE) in Q3 2014, closing a stake of 135,755 shares — an estimated $3.82M sold.

Hotchkis & Wiley Capital Management first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $6.24M in Q1 2014. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Hotchkis & Wiley Capital Management reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 135,755 Pfizer shares in Q3 2014, an estimated $3.82M.
  • Hotchkis & Wiley Capital Management first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
  • Hotchkis & Wiley Capital Management's Pfizer position peaked at $6.24M in Q1 2014.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.